This page has a number of charts on vaccination. In the box below you can select any country you are interested in – or several, if you want to compare countries.
All charts on this page will then show data for the countries that you selected.
Tracking COVID-19 vaccination rates is crucial to understand the scale of protection against the virus, and how this is distributed across the global population.
A global, aggregated database on COVID-19 vaccination rates is essential to monitor progress, but it is unfortunately not yet available. When a global, or aggregated regional database — such as European data collated by the European CDC — becomes available, Our World in Data will provide these weekly updates of vaccination rates, presented in our interactive COVID-19 Explorer, and our Complete COVID-19 Dataset.
Until such a database is made available, Our World in Data will be tracking recent announcements on the first countries to administer these vaccinations. Our sources for the data presented here are listed at the bottom of this page.
The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).
The following map and chart show the total number of COVID-19 vaccination doses administered. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).
The metrics above provide the total number of doses administered — the cumulative doses over time.
The following map and chart show the daily number of COVID-19 vaccination doses administered. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).
The following map and chart show the daily number of COVID-19 vaccination doses administered per million people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).
This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.
Countries are grouped into six categories:
- No availability
- Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
- Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
- Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
- Availability for all three plus partial additional availability (select broad groups/ages)
- Universal availability
Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker
This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).
This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.
The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.
The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.
These charts are regularly updated based on the latest version of the response tracker.
OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.
The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which we’ve known the pathogens for more than a century (like malaria) we still haven’t found an effective vaccine.
The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries.
The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.
Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed:
- The London School of Hygiene & Tropical Medicine Vaccine Tracker is updated weekly and shows the current stage of each development.
- WHO Vaccine Tracker – The WHO is tracking the COVID-19 candidate vaccines that are under development.
- Milken Institute Vaccine Tracker – The Milken Institute publishes, and regularly updates a tracker of possible treatments and vaccines for COVID-19 that scientists are currently working on.
- New York Times – The NYT tracker includes brief summaries of each development.
You can download the full dataset alongside the detailed source descriptions on GitHub.
Note that other countries have also started vaccination campaigns—we’ll add them to our maps and charts as soon as numbers are verifiable based on public official sources.
We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.
| Location | Source | Last observation date | Vaccines |
|---|---|---|---|
| Argentina | Government of Argentina | January 8, 2021 | Sputnik V |
| Austria | Ministry of Health | December 30, 2020 | Pfizer/BioNTech |
| Bahrain | Ministry of Health | January 8, 2021 | Sinopharm |
| Belgium | Government vaccination taskforce | January 2, 2021 | Pfizer/BioNTech |
| Bulgaria | Ministry of Health | January 9, 2021 | Pfizer/BioNTech |
| Canada | COVID-19 Canada Open Data Working Group | January 8, 2021 | Moderna, Pfizer/BioNTech |
| Chile | Department of Statistics and Health Information | January 6, 2021 | Pfizer/BioNTech |
| China | National Health Commission | January 9, 2021 | CNBG, Sinovac |
| Costa Rica | National Health Commission | January 8, 2021 | Pfizer/BioNTech |
| Croatia | Ministry of Health | January 8, 2021 | Pfizer/BioNTech |
| Cyprus | Ministry of Health | January 6, 2021 | Pfizer/BioNTech |
| Czechia | Ministry of Health | January 6, 2021 | Pfizer/BioNTech |
| Denmark | Statens Serum Institut | January 8, 2021 | Pfizer/BioNTech |
| England | Government of the United Kingdom | January 3, 2021 | Pfizer/BioNTech |
| Estonia | National Health Board | January 9, 2021 | Pfizer/BioNTech |
| Finland | THL via Helsingin Sanomat | January 8, 2021 | Pfizer/BioNTech |
| France | Ministry of Health | January 8, 2021 | Pfizer/BioNTech |
| Germany | Robert Koch Institut | January 7, 2021 | Pfizer/BioNTech |
| Greece | Ministry of Health | January 8, 2021 | Pfizer/BioNTech |
| Guinea | National Health Security Agency | December 30, 2020 | Sputnik V |
| Hungary | Government of Hungary | January 8, 2021 | Pfizer/BioNTech |
| Iceland | Directorate of Health | December 30, 2020 | Pfizer/BioNTech |
| Ireland | Health Service Executive | January 7, 2021 | Pfizer/BioNTech |
| Israel | Government of Israel | January 7, 2021 | Pfizer/BioNTech |
| Italy | Extraordinary commissioner for the Covid-19 emergency | January 9, 2021 | Pfizer/BioNTech |
| Kuwait | Ministry of Health | December 28, 2020 | Pfizer/BioNTech |
| Latvia | National Health Service | January 8, 2021 | Pfizer/BioNTech |
| Lithuania | Ministry of Health | January 8, 2021 | Pfizer/BioNTech |
| Luxembourg | Government of Luxembourg | December 30, 2020 | Pfizer/BioNTech |
| Malta | Ministry of Health | January 3, 2021 | Pfizer/BioNTech |
| Mexico | Secretary of Health | January 8, 2021 | Pfizer/BioNTech |
| Netherlands | National Institute for Public Health and the Environment | January 8, 2021 | Pfizer/BioNTech |
| Northern Ireland | Government of the United Kingdom | January 3, 2021 | Pfizer/BioNTech |
| Norway | Norwegian Institute of Public Health | January 7, 2021 | Pfizer/BioNTech |
| Oman | Ministry of Health | January 8, 2021 | Pfizer/BioNTech |
| Poland | Ministry of Health | January 8, 2021 | Pfizer/BioNTech |
| Portugal | National Health Service | January 8, 2021 | Pfizer/BioNTech |
| Romania | Government of Romania | January 8, 2021 | Pfizer/BioNTech |
| Russia | Government of Russia | January 2, 2021 | Sputnik V |
| Saudi Arabia | Ministry of Hajj and Umrah | January 6, 2021 | Pfizer/BioNTech |
| Scotland | Government of the United Kingdom | January 3, 2021 | Pfizer/BioNTech |
| Slovakia | Ministry of Health | January 7, 2021 | Pfizer/BioNTech |
| Slovenia | National Institute of Public Health, via Sledilnik | January 8, 2021 | Pfizer/BioNTech |
| Spain | Ministry of Health | January 8, 2021 | Pfizer/BioNTech |
| Sweden | Swedish Medical Products Agency | January 4, 2021 | Pfizer/BioNTech |
| United Arab Emirates | National Emergency Crisis and Disaster Management Authority | January 8, 2021 | Sinopharm |
| United Kingdom | Government of the United Kingdom | January 3, 2021 | Pfizer/BioNTech |
| United States | Centers for Disease Control and Prevention | January 8, 2021 | Moderna, Pfizer/BioNTech |
| Wales | Government of the United Kingdom | January 3, 2021 | Pfizer/BioNTech |
Sign up for regular updates from Our World in Data
→ If you want to keep up-to-date with on our work on COVID-19, and the many other topics we cover you can sign up to our newsletter.
